{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T10:09:40Z","timestamp":1782641380525,"version":"3.54.5"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although much less common than deep vein thrombosis of the lower extremities or lungs, clots in unusual locations, including the splanchnic, cerebral, retinal, upper-extremity, and renal locations, present with significant morbidity and mortality. In the last 2 decades, treatment of clots in these unusual locations is primarily managed medically, with interventional and surgical approaches reserved for more severe or refractory cases. The hematologist is well positioned to provide consultation to organ-specific specialties (ie, neurosurgery, hepatology, ophthalmology), especially because acquired and congenital hypercoagulability plays a major role, and anticoagulation is often the primary treatment. Historically, treatment has been based on expert opinion, but systematic reviews and meta-analyses have recently been published. Various societies have produced guidelines for the treatment of clots in unusual locations; however, randomized clinical trial data remain scarce. In the last few years, increasing data have emerged concerning the efficacy of the direct oral anticoagulants in treating clots in unusual locations. Cases have recently been described highlighting atypical thrombosis associated with COVID-19 infection as well as with the ChAdOx1 nCoV-19 (AstraZeneca) vaccine and Johnson and Johnson's Janssen Ad26.COV2.S vaccine. This article reviews clots in unusual locations with an emphasis on the splanchnic (mesenteric, portal, splenic, hepatic) and cerebral circulation. Through a case-based approach, key questions are posed, and data are presented to help guide diagnosis and treatment.<\/jats:p>","DOI":"10.1182\/hematology.2021000237","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:23:29Z","timestamp":1639139009000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Clots in unusual places: lots of stress, limited data, critical decisions"],"prefix":"10.1182","volume":"2021","author":[{"given":"Carol","family":"Mathew","sequence":"first","affiliation":[{"name":"Internal Medicine, Division of Hematology\/Oncology, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zumberg","sequence":"additional","affiliation":[{"name":"Internal Medicine, Division of Hematology\/Oncology, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"2021121012094189700_hem2021000237C1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/B978-1-4557-2296-9.00017-8","article-title":"Venous thromboses at unusual sites","volume-title":"Consultative Hemostasis and Thrombosis","author":"Rajasekhar","year":"2013","edition":"3rd"},{"issue":"5","key":"2021121012094189700_hem2021000237C2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood.2019000918","article-title":"Treatment of unusual thrombotic manifestations","volume":"135","author":"Abbattista","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2021121012094189700_hem2021000237C3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/jcm9030743","article-title":"Cerebral and splanchnic vein thrombosis: advances, challenges, and unanswered questions","volume":"9","author":"Riva","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"2021121012094189700_hem2021000237C4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ejh.13177","article-title":"Venous thrombosis in unusual sites: a practical review for the hematologist","volume":"102","author":"Shatzel","year":"2019","journal-title":"Eur J Haematol"},{"issue":"15 December","key":"2021121012094189700_hem2021000237C5","doi-asserted-by":"crossref","first-page":"117183","DOI":"10.1016\/j.jns.2020.117183","article-title":"Cerebral venous sinus thrombosis associated with SARS-CoV-2: a multinational case series","volume":"419","author":"Mowla","year":"2020","journal-title":"J Neurol Sci"},{"issue":"12","key":"2021121012094189700_hem2021000237C6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.dld.2020.09.025","article-title":"Splanchnic vein thrombosis in COVID-19: a review of literature","volume":"52","author":"Singh","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"22","key":"2021121012094189700_hem2021000237C7","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"2021121012094189700_hem2021000237C8","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2021121012094189700_hem2021000237C9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC subcommittee on platelet immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2021121012094189700_hem2021000237C10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/rth2.12424","article-title":"Anticoagulation in splanchnic and cerebral vein thrombosis: an international vignette-based survey","volume":"4","author":"Riva","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"7","key":"2021121012094189700_hem2021000237C11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC subcommittee control of anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2021121012094189700_hem2021000237C12","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s10620-020-06485-y","article-title":"An update on the management of Budd-Chiari syndrome","volume":"66","author":"Sharma","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"9","key":"2021121012094189700_hem2021000237C13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2021121012094189700_hem2021000237C14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb Haemost"},{"issue":"1","key":"2021121012094189700_hem2021000237C15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2020.06.045","article-title":"Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis","volume":"74","author":"Magaz","year":"2021","journal-title":"J Hepatol"},{"issue":"6","key":"2021121012094189700_hem2021000237C16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"issue":"7","key":"2021121012094189700_hem2021000237C17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"121","author":"Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"issue":"1","key":"2021121012094189700_hem2021000237C18","first-page":"104","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"34","author":"Ghazaleh","year":"2021","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"2021121012094189700_hem2021000237C19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL Clinical Practice Guidelines: vascular diseases of the liver","volume":"64","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J Hepatol"},{"issue":"suppl 2","key":"2021121012094189700_hem2021000237C20","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"6","key":"2021121012094189700_hem2021000237C21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s11605-020-04624-4","article-title":"Systematic review of thrombolysis therapy in the management of non-cirrhosis-related portal vein thrombosis","volume":"25","author":"Cheng","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"2021121012094189700_hem2021000237C22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/liv.13180","article-title":"Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome","volume":"37","author":"Tripathi","year":"2017","journal-title":"Liver Int"},{"issue":"9","key":"2021121012094189700_hem2021000237C23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S2468-1253(19)30177-3","article-title":"Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial","volume":"4","author":"Wang","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2021121012094189700_hem2021000237C24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1457496920969084","article-title":"Management of acute mesenteric venous thrombosis: a systematic review of contemporary studies","volume":"110","author":"Acosta","year":"2020","journal-title":"Scand J Surg"},{"issue":"May","key":"2021121012094189700_hem2021000237C25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.avsg.2019.11.015","article-title":"Evaluation of endovascular therapy combined with bowel resection treatment on patients with acute mesenteric venous thrombosis","volume":"65","author":"Liu","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"August","key":"2021121012094189700_hem2021000237C26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.avsg.2016.02.019","article-title":"Postoperative catheter-directed thrombolysis versus systemic anticoagulation for acute superior mesenteric venous thrombosis","volume":"35","author":"Yang","year":"2016","journal-title":"Ann Vasc Surg"},{"issue":"11","key":"2021121012094189700_hem2021000237C27","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1007\/s00268-018-4667-x","article-title":"Improved prognosis and low failure rate with anticoagulation as first-line therapy in mesenteric venous thrombosis","volume":"42","author":"Salim","year":"2018","journal-title":"World J Surg"},{"issue":"10","key":"2021121012094189700_hem2021000237C28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ene.13381","article-title":"European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis\u2014endorsed by the European Academy of Neurology","volume":"24","author":"Ferro","year":"2017","journal-title":"Eur J Neurol"},{"issue":"10","key":"2021121012094189700_hem2021000237C29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"8767","key":"2021121012094189700_hem2021000237C30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-Q","article-title":"Heparin treatment in sinus venous thrombosis","volume":"338","author":"Einh\u00e4upl","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"2021121012094189700_hem2021000237C31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.STR.30.3.484","article-title":"Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis","volume":"30","author":"de Bruijn","year":"1999","journal-title":"Stroke"},{"issue":"3","key":"2021121012094189700_hem2021000237C32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"issue":"May","key":"2021121012094189700_hem2021000237C33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amsu.2017.03.016","article-title":"Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: a systematic review and meta-analysis","volume":"17","author":"Qureshi","year":"2017","journal-title":"Ann Med Surg (Lond)"},{"issue":"7","key":"2021121012094189700_hem2021000237C34","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"suppl 2","key":"2021121012094189700_hem2021000237C35","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Lansberg","year":"2012","journal-title":"Chest"},{"issue":"2","key":"2021121012094189700_hem2021000237C36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1747-4949.2011.00753.x","article-title":"Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial","volume":"8","author":"Coutinho","year":"2013","journal-title":"Int J Stroke"},{"issue":"7","key":"2021121012094189700_hem2021000237C37","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1538-7836.2012.04774.x","article-title":"Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study","volume":"10","author":"Dentali","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2021121012094189700_hem2021000237C38","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.020","article-title":"A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study","volume":"26","author":"Duman","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"2021121012094189700_hem2021000237C39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1747493018778137","article-title":"The benefit of EXtending oral antiCOAgulation treatment (EXCOA) after acute cerebral vein thrombosis (CVT): EXCOA-CVT cluster randomized trial protocol","volume":"13","author":"Miranda","year":"2018","journal-title":"Int J Stroke"},{"issue":"5","key":"2021121012094189700_hem2021000237C40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/STROKEAHA.114.007465","article-title":"Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases","volume":"46","author":"Siddiqui","year":"2015","journal-title":"Stroke"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/92\/1851781\/92mathew.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/92\/1851781\/92mathew.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:24:06Z","timestamp":1639139046000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2021\/1\/92\/482935\/Clots-in-unusual-places-lots-of-stress-limited"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2021000237","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,10]]},"published":{"date-parts":[[2021,12,10]]}}}